Details
| Name | miR-291a-3p |
| Type | miRNA |
| Species | Homo sapiens |
| Tissue | skin |
| Experiment Method | SA-B-gal staining,Real-time PCR,Western blot |
| Up/Down | Down |
| Pro/Anti | anti |
| Funtion Description | Treatment of senescent cells with mmu-miR-291a-3p decreased senescence-associated-B-galactosidase activity, enhanced proliferative potential, and reduced mRNA and protein expression of TGFBR2, p53, and p21. |
| Regulation Gene | TGFBR2 |
| Year | 2018 |
| Pubmed ID | 30239625 |
| Title | Embryonic stem cell-derived mmu-miR-291a-3p inhibits cellular senescence in human dermal fibroblasts through the TGF-B-receptor 2 pathway. |
| Drug | adriamycin |
| Disease | NA |
| Environment Factors | ionizing radiation |
| Circulating | NA |
| Variant | NA |
| High-throughput | NA |